Lie Ming Ding
Chief Executive Officer presso BETTA PHARMACEUTICALS CO., LTD.
Patrimonio netto: 64 M $ in data 29/02/2024
Profilo
Fondatore della Betta Pharmaceuticals Co., Ltd., Lie Ming Ding è attualmente Presidente, Co-Chief Executive Officer & GM della Betta Pharmaceuticals Co., Ltd. e General Manager & Executive Director della Ningbo Kaiming Venture Technology Co., Ltd., Presidente & General Manager della Zhejiang Betta Pharmaceuticals Co. Ltd. (una filiale di Ningbo Kaiming Venture Technology Co., Ltd.). Il Dr. Ding è anche nel consiglio di amministrazione di Betta Investment (Hong Kong) Ltd. In passato è stato Senior Research Associate-Cancer Institute presso l'Università dell'Arkansas. Lie Ming Ding ha ricevuto un dottorato dall'Università dell'Arkansas.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
30/09/2023 | 9 924 563 ( 2.40% ) | 60 M $ | 29/02/2024 | |
30/09/2023 | 739 978 ( 56.97% ) | 4 M $ | 29/02/2024 |
Posizioni attive di Lie Ming Ding
Società | Posizione | Inizio |
---|---|---|
BETTA PHARMACEUTICALS CO., LTD. | Chief Executive Officer | 23/08/2013 |
Betta Investment (Hong Kong) Ltd.
Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Director/Board Member | - |
Zhejiang Betta Pharmaceuticals Co., Ltd.
Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Chief Executive Officer | - |
Ningbo Kaiming Venture Technology Co., Ltd.
Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Chief Executive Officer | - |
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Director/Board Member | 20/06/2022 |
Precedenti posizioni note di Lie Ming Ding
Società | Posizione | Fine |
---|---|---|
The University of Arkansas | Corporate Officer/Principal | - |
Formazione di Lie Ming Ding
The University of Arkansas | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
Aziende private | 4 |
---|---|
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Health Technology |
Betta Investment (Hong Kong) Ltd.
Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Finance |
Zhejiang Betta Pharmaceuticals Co., Ltd.
Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Commercial Services |
Ningbo Kaiming Venture Technology Co., Ltd.
Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Technology Services |